RVOT3V79
RVOT3V79
RVOT3V79
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
242 Fuentes-Biggi J, Ferrari-Arroyo MJ, Boada-Muñoz L, Tourino-Aguilera<br />
E, Artigas-Pallarés J, Belinchon-Carmona M, et al. Good practice<br />
guidelines for the treatment of autistic spectrum disorders. Rev Neurol.<br />
2006 Oct 1;43(7):425-38.<br />
243 Posey DJ, Wiegand RE, Wilkerson J, Maynard M, Stigler KA, McDougle<br />
CJ. Open-label atomoxetine for attention-deficit/hyperactivity<br />
disorder symptoms associated with high-functioning pervasive developmental<br />
disorders. J Child Adolesc Psychopharmacol. 2006 Oct;16(5):<br />
599-610.<br />
244 Troost PW, Steenhuis MP, Tuynman-Qua HG, Kalverdijk LJ, Buitelaar<br />
JK, Minderaa RB, et al. Atomoxetine for Attention-Deficit/Hyperactivity<br />
Disorder Symptoms in Children with Pervasive Developmental<br />
Disorders: A Pilot Study. J Child Adolesc Psychopharmacology. 2006<br />
Oct;16(5):611-9.<br />
245 Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen<br />
PS, et al. The Texas Children’s Medication Algorithm Project: revision<br />
of the algorithm for pharmacotherapy of attention-deficit/hyperactivity<br />
disorder. J Am Acad Child Adolesc Psychiatry. 2006 Jun;45(6):<br />
642-57.<br />
246 Sumner CS, Donnelly C, Lopez FA, Sutton V, Bakken R, Paczkowski<br />
M, et al. Atomoxetine treatment for pediatric patients with ADHD<br />
and comorbid anxiety. Presentado en: Annual Meeting of the American<br />
Psychiatric Association. 2005.<br />
247 Bangs ME, Emslie GJ, Spencer T, Ramsey Jl, Detke HC, Allen AJ, et<br />
al. A study of atomoxetine in adolescents with ADHD and comorbid<br />
depression. 2005.<br />
248 McClellan J, Kowatch RA, Findling RL. Practice Parameter for the<br />
Assessmentand Treatment of Children and Adolescents With Bipolar<br />
Disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(1):107-125.<br />
249 State RC, Frye MA, Altshuler LL. Chart review of the impact of attention-deficit/hyperactivity<br />
disorder comorbidity on respondse to lithium<br />
of divalproex sodium in adolescent mania. J Clin Psychiatry.<br />
2004;65:1057-63.<br />
250 Consoli A, Bouzamondo A, Guile JM, Lechat P, Cohen D. Comorbidity<br />
with ADHD decreases response to pharmacotherapy in children<br />
and adolescents with acute mania: evidence from a metaanalysis. Can<br />
J Psychiatry. 2007 May;52(5):323-8.<br />
251 Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander<br />
M. Treatment guidelines for children and adolescents with bipolar<br />
disorder. J Am Acad Child Adolesc Psychiatry. 2005 Mar;44(3):213-35.<br />
252 Biederman J, Mick E, Prince J, Bostic JQ, Wilens TE, Spencer T, et al.<br />
Systematic chart review of the pharmacologic treatment of comorbid<br />
Guía DE PráCtICa CLíNICa SOBrE EL traStOrNO POr DéfICIt DE<br />
atENCIóN CON hIPEraCtIvIDaD (tDah) EN NIñOS y aDOLESCENtES<br />
191
Change language